Researchers of the Department of Medical Biotechnology at the Paul Ehrlich Institute led by Prof. Dr. Gerald Schumann have discovered by which mechanism a group of retrotransposons called SVA elements is distributed in the human genome. Their insights are also significant for stem cell research.
Led by Dr. Michael Mühlebach, and in cooperation with international research groups from the USA, Canada, Singapore and France, researchers from the medical biotechnology department at the Paul-Ehrlich Institute have shed light on how measles viruses penetrate epithelial cells, from where they are expelled via the respiratory tract and infect other humans.
Researchers from the Berlin Max Planck Institute of Molecular Genetics led by Markus Ralser have developed a reliable and easy to handle method for analysing proteins in a mass spectrometer. They use an especially sensitive triple-quadrupole mass spectrometer coupled to a high pressure liquid chromatograph.
In a collaborative research project, scientists from the University Hospital Erlangen under the direction of Prof. Dr. med. Jürgen Winkler in the Department of Molecular Neurology, the Salk Institute for Biological Studies under Fred Gage and the University of California San Diego (UCSD) in La Jolla aim to use stem cells and immune cells to find out what part inflammation processes play in Parkinson’s disease.
By screening red blood cell proteins in a protein database (ARVEXIS), Gavin Wright and his team from the Wellcome Trust Sanger Institute in Hinxton, UK, have identified a receptor-ligand pair which is of fundamental significance regarding the invasion of human red blood cells by Plasmodium falciparum, the malaria pathogen.
Between the 3rd and 4th of November 2011, more than twenty participants from university medical faculties, science and technology institutes, companies and government bodies took part in the first Cultex workshop in Hannover, Germany, devoted to current inhalation toxicity issues.
An experiment conducted by the Institute of Micro and Nanomaterials at the Ulm University demonstrates that it may be possible to develop a new treatment for Alzheimer’s disease using an active agent from green tea in combination with red laser light.
The number of experiments conducted on animals once again rose in 2010, according to a report published by the German Federal Ministry of Food, Agriculture and Consumer Protection (BMELV).
At the beginning of October, the first major European project of the "International Human Epigenome Project" (IHEC) started in Amsterdam. The project is an international joint cooperation and includes German scientists.
Recently a research team from Austria and China succeded in producing induced pluripotent stem cells (iPS) from human urine. They have applied to patent the method.